BioSpace News Archive

Lone Star Bio

Castle Biosciences to Present at the Baird 2018 Global Healthcare Conference

Castle Biosciences, Inc. today announced that Derek Maetzold, President and CEO, will present at the Baird Global Healthcare Conference on Wednesday, September 5th, 2018 at 11:25 a.m. ET in New York City.

August 30, 2018
·
1 min read
FDA

U.S. Food and Drug Administration Accepts Bristol-Myers Squibb’s Application for Sprycel (dasatinib) in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Application based on results from Phase 2 CA180-372 study

August 30, 2018
·
14 min read
Business

Patterson Companies Reports Fiscal 2019 First-Quarter Results

First-quarter reported net sales totaled $1.3 billion, up 2.5 percent.

August 30, 2018
·
14 min read
Business

FirstLight Home Care is Coming to St. Augustine Area

National non-medical home care provider announces new location to serve the St. Augustine and Jacksonville areas

August 30, 2018
·
1 min read
Business

Curaleaf Opens Lakeland’s First Medical Marijuana Dispensary

Dispensary Offers FREE Same-Day, Next-Day Delivery Service in Lakeland and surrounding communities

August 30, 2018
·
2 min read
Business

GT Biopharma’s Chairman and Chief Executive Officer Raymond W Urbanski, M.D., Ph.D Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Collaboration

GT Biopharma Inc. is an immuno-oncology biotechnology company focused on innovative treatments based on the company’s proprietary NK-engager and Bispecific Antibody Drug Conjugate platforms.

August 30, 2018
·
5 min read
Genetown

Haemonetics to Present at Morgan Stanley’s Global Healthcare Conference on September 13, 2018

Haemonetics Corporation announced that Chris Simon, President and CEO, will present at Morgan Stanley’s Global Healthcare Conference in New York on Thursday, September 13, 2018 at 11:10am Eastern time.

August 30, 2018
·
1 min read
Pharm Country

PDL BioPharma to Present at the H.C. Wainwright 20th Annual Global Investment Conference

PDL BioPharma, Inc. announces that John McLaughlin, PDL’s chief executive officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference.

August 30, 2018
·
2 min read
Biotech Bay

NovaBay Pharmaceuticals to Present at H.C. Wainwright 20th Annual Global Investment Conference on September 6

NovaBay® Pharmaceuticals, Inc. announces that management is scheduled to present a corporate overview at the H.C. Wainwright 20th Annual Global Investment Conference on Thursday, September 6, 2018

August 30, 2018
·
1 min read
Drug Development

Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy

Pfizer Inc.. (NYSE: PFE) announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).

August 30, 2018
·
7 min read